Last reviewed · How we verify

Bupivacaine Hydrochloride combined with dexamethasone

Zhejiang Cancer Hospital · FDA-approved active Small molecule

Bupivacaine Hydrochloride combined with dexamethasone is a Local anesthetic with corticosteroid adjuvant Small molecule drug developed by Zhejiang Cancer Hospital. It is currently FDA-approved for Local and regional anesthesia for surgical procedures, Post-operative pain management. Also known as: SB Group (control group).

Bupivacaine provides local anesthesia by blocking sodium channels in nerve fibers, while dexamethasone reduces inflammation and edema at the injection site.

Bupivacaine provides local anesthesia by blocking sodium channels in nerve fibers, while dexamethasone reduces inflammation and edema at the injection site. Used for Local and regional anesthesia for surgical procedures, Post-operative pain management.

At a glance

Generic nameBupivacaine Hydrochloride combined with dexamethasone
Also known asSB Group (control group)
SponsorZhejiang Cancer Hospital
Drug classLocal anesthetic with corticosteroid adjuvant
TargetVoltage-gated sodium channels (bupivacaine); glucocorticoid receptor (dexamethasone)
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhaseFDA-approved

Mechanism of action

Bupivacaine is a long-acting local anesthetic that inhibits sodium influx through nerve cell membranes, preventing depolarization and blocking pain signal transmission. Dexamethasone, a corticosteroid, is combined to reduce post-operative inflammation, swelling, and pain duration by suppressing inflammatory mediators. This combination extends anesthetic duration and improves post-operative analgesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Bupivacaine Hydrochloride combined with dexamethasone

What is Bupivacaine Hydrochloride combined with dexamethasone?

Bupivacaine Hydrochloride combined with dexamethasone is a Local anesthetic with corticosteroid adjuvant drug developed by Zhejiang Cancer Hospital, indicated for Local and regional anesthesia for surgical procedures, Post-operative pain management.

How does Bupivacaine Hydrochloride combined with dexamethasone work?

Bupivacaine provides local anesthesia by blocking sodium channels in nerve fibers, while dexamethasone reduces inflammation and edema at the injection site.

What is Bupivacaine Hydrochloride combined with dexamethasone used for?

Bupivacaine Hydrochloride combined with dexamethasone is indicated for Local and regional anesthesia for surgical procedures, Post-operative pain management.

Who makes Bupivacaine Hydrochloride combined with dexamethasone?

Bupivacaine Hydrochloride combined with dexamethasone is developed and marketed by Zhejiang Cancer Hospital (see full Zhejiang Cancer Hospital pipeline at /company/zhejiang-cancer-hospital).

Is Bupivacaine Hydrochloride combined with dexamethasone also known as anything else?

Bupivacaine Hydrochloride combined with dexamethasone is also known as SB Group (control group).

What drug class is Bupivacaine Hydrochloride combined with dexamethasone in?

Bupivacaine Hydrochloride combined with dexamethasone belongs to the Local anesthetic with corticosteroid adjuvant class. See all Local anesthetic with corticosteroid adjuvant drugs at /class/local-anesthetic-with-corticosteroid-adjuvant.

What development phase is Bupivacaine Hydrochloride combined with dexamethasone in?

Bupivacaine Hydrochloride combined with dexamethasone is FDA-approved (marketed).

What are the side effects of Bupivacaine Hydrochloride combined with dexamethasone?

Common side effects of Bupivacaine Hydrochloride combined with dexamethasone include Injection site reactions (pain, swelling), Transient nerve irritation, Systemic toxicity from bupivacaine (rare), Hyperglycemia (from dexamethasone).

What does Bupivacaine Hydrochloride combined with dexamethasone target?

Bupivacaine Hydrochloride combined with dexamethasone targets Voltage-gated sodium channels (bupivacaine); glucocorticoid receptor (dexamethasone) and is a Local anesthetic with corticosteroid adjuvant.

Related